- Report
- April 2026
- 373 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 282 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 372 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 394 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 364 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 274 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 384 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 361 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 278 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 386 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 273 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 270 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 379 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 114 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 375 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 279 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 183 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 179 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 258 Pages
Global
From €5125EUR$5,850USD£4,458GBP
- Report
- April 2026
- 196 Pages
Global
From €5125EUR$5,850USD£4,458GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more